All medications within these trials are once weekly subcutaneously-administered injections
Different comparison groups Clinical trials compared semaglutide to placebo or active comparators within the same trial
Eli Lilly announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety & efficacy of Retatrutide, a first-in-class GIP, GLP-1 & glucagon triple hormone receptor agonist, in adults with obesity or overweight & knee osteoarthritis
Wegovy also works to slow down digestion
It represents the next generation of metabolic research peptides, designed to enhance energy expenditure, improve glucose control, and accelerate fat loss beyond what dual-agonists like Tirzepatide can achieve
Fast, discreet delivery Once approved, your prescription is compounded and shipped in discreet packaging